We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-30.19%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
–
Cap. Flow
+$125M
Cap. Flow %
119.88%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ACHL
Achilles Therapeutics
ACHL
+$67.1M
2
AUTL
Autolus Therapeutics
AUTL
+$44.1M
3
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$8.03M
4
ADAP
Adaptimmune Therapeutics
ADAP
+$6.27M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHL
1
DELISTED
Achilles Therapeutics
ACHL
$55.5M 53.06%
+11,086,909
New +$67.1M
AUTL
2
Autolus Therapeutics
AUTL
$386M
$38.1M 36.42%
+7,346,829
New +$44.1M
FRLN
3
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$5.84M 5.58%
+196,667
New +$8.03M
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$5.17M 4.93%
+1,377,294
New +$6.27M

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
FCC
Florin Court Capital London, United Kingdom $26.5M AUM 34.2% 1-Year Est. Return
BWG
Berry Wealth Group Granbury, Texas $26.8M AUM 31.56% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $27M AUM
TCM
Teza Capital Management Chicago, Illinois $27.3M AUM 29.09% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
Bancreek Capital Management Santa Monica, California $23.1M AUM 4.01% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return

Syncona Portfolio's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Syncona Portfolio, which disclosed 4 positions worth $105M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Achilles Therapeutics: 11,086,909 shares worth $55.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Syncona Portfolio's largest Q4 2021 buy was Achilles Therapeutics: 11,086,909 shares worth $55.5M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $105M portfolio in Q4 2021.
  • Syncona Portfolio disclosed 4 positions in Q4 2021, its first 13F filing on record.

Based on Syncona Portfolio's 13F filing for Q4 2021, filed 11 Feb 2022.